Tabula Rasa HealthCare, Inc. revised preliminary revenue guidance for the fourth quarter 2022 . Revenue from continuing operations for the fourth quarter of 2022 is expected to be between $82 $83 million, exceeding the prior guidance range of $77.5 $80.5 million.
Tabula Rasa HealthCare, Inc.
Equities
TRHC
US8733791011
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+6.88% | 33.25B | |
+20.58% | 7.96B | |
+32.03% | 4.25B | |
-29.55% | 2.67B | |
-27.55% | 1.28B | |
-30.53% | 1.2B | |
+11.69% | 999M | |
-35.42% | 902M | |
-22.19% | 686M |